Product Images Atorvastatin Calcium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Atorvastatin Calcium NDC 77771-451 by Radha Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
atorvastatin-10mg-1000tab - atorvastatin 10mg 1000tab
atorvastatin-10mg-90tab - atorvastatin 10mg 90tab
This is a description for Atorvastatin Calcium tablets. Each film-coated tablet contains 10 mg of atorvastatin. The usual dosage and storage instructions can be found in the accompanying prescribing information. The medication should be kept in a tight, child-resistant container and it is important to keep it out of the reach of children. The tablets are manufactured by Scieben Pharmaceuticals, Inc. and distributed by Radha Pharmaceuticals, Inc. The NDC (National Drug Code) is 77771-451-90.*
atorvastatin-20mg-500tab - atorvastatin 20mg 500tab
atorvastatin-20mg-90tab - atorvastatin 20mg 90tab
atorvastatin-40mg-1000tab - atorvastatin 40mg 1000tab
atorvastatin-40mg-90tab - atorvastatin 40mg 90tab
atorvastatin-80mg-500tab - atorvastatin 80mg 500tab
atorvastatin-80mg-90tab - atorvastatin 80mg 90tab
chemical-structure - chemical structure
Figure-01 - figure 1
This text appears to be displaying statistical information about a cumulative incidence rate. The numbers 40, 15, 20, 25, 30, and 35 might be representing different time points or intervals in years. The text mentions a hazard ratio (HR) of 0.64 with a corresponding confidence interval (0.50-0.83) and a p-value of 0.0005. Without further context, it is difficult to determine the specific meaning or context of the presented data.*
Figure-02 - figure 2
This text provides information on the Cumulative Hazard (%) and the comparison between Placebo and Atorvastatin. The Hazard Ratio (HR) for Atorvastatin compared to Placebo is 0.63, with a 95% confidence interval of 0.48-0.83, and a p-value of 0.001. The graph shows the time to the first primary endpoint over a follow-up period of four years.*
Figure-03 - figure 3
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.